DCGI's SEC to review applications of Bharat Biotech, SII for...
New Delhi [India], January 14 (ANI): Drugs Controller General of India (DCGI)'s Subject Expert Committee will...
COVID-19: Oral anti-viral drug Molnupiravir is not included...
New Delhi [India], January 5 (ANI): Indian Council of Medical Research (ICMR) head Dr. Balram Bhargava on...
DCGI approves India-made RT-PCR kit to detect Omicron: Centre
New Delhi [India], January 5 (ANI): An RT-PCR test kit for detecting new coronavirus variant Omicron has been...
Bharat Biotech gets SEC approval for phase 3 clinical trials...
New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India...
SEC to hold meeting on Bharat Biotech's Nasal vaccine booster dose
Dr Dangs Lab as central lab conducted tests in all three...
New Delhi [India], December 29 (ANI): With the Drug Controller General of India (DCGI) approving two new COVID-19...
Covovax authorisation is a vital step in India, where...
Gaithersburg/Pune (Maryland/Maharashtra)[US/India], December 29 (ANI): Novavax, Inc. (Nasdaq: NVAX), a...
Affordable, effective COVID-19 vaccine Corbevax to be...
Biological E gets approval to conduct trials of Corbevax as...
New Delhi [India], December 29 (ANI): The Drug Controller General of India (DCGI) has given approval to the...
Dr Reddy's laboratories gets DCGI's nod to launch...
DCGI grants Cipla emergency use authorisation for COVID-19...
Optimus Pharma granted permission for restricted use under...
Copyright © aninews.in | All Rights Reserved.